Classification of calcium channels and calcium antagonists: progress report.
The molecular biology and electrophysiology of calcium channels is proceeding apace, partially driven by the clinical success of the drugs classed as "calcium antagonists." Indeed, there are now more than 70 drugs in development that have been claimed to be "calcium antagonists" of one type or another. In order to ensure that there is a logical nomenclature for the channels and the drugs acting at the channels, an international committee has met over the last 2 years to classify the channels and the drugs. This report consists of an overview of current thinking, which will be finalized in a document submitted to the IUPHAR (International Union of Pharmacologists) nomenclature committee.
Spedding
M
M
Department of Pharmacology, Syntex Research Centre, Riccarton, Edinburgh, Scotland.
Paoletti
R
R
D002121:Calcium Channel Blockers / Q000145:classification*; D015220:Calcium Channels
D002121:Calcium Channel Blockers; D015220:Calcium Channels